articleThe Lancet Infectious DiseasesJun 17, 2025GREEN OA

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

JMJohan MaertensGRGeorge R. ThompsonASAndrej SpecFDFariba DonovanSPSarah P. Hammond

KU Leuven · University of California Davis Medical Center · +57 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

55
total citations
FWCI
59.71
Percentile
100%
References
33
Citations per year

Authors

54

Topics & keywords

Topics
Keywords
  • Medicine
  • Phase (matter)
  • Intensive care medicine
  • Chemistry
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.

Funding